Combination Product Rules Clear OMB, To Be Released In Weeks
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's general idea is for companies to choose one operating system, drug or device, then tack on procedures certain components require, not follow different rules for different components, agency expert says at RAPS.